Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,815,161
+$363,409 QoQ
Shares Held
374,260
-39.7% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#29
of 114 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. ZNTL ranks #11 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 14,986,947 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in ZNTL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,815,161 374,260
2026-03-31 $1,451,752 620,407
2025-12-31 $1,578,923 1,169,573
2025-09-30 $1,627,260 1,077,656
2025-06-30 $1,314,715 1,133,375
2025-03-31 $861,740 541,975
2024-12-31 $436,835 144,170
2024-09-30 $2,239,592 608,585
2024-06-30 $1,043,772 255,201
2024-03-31 $167,087 10,602
2023-09-30 $488,340 24,344
2022-03-31 $598,851 12,979
2021-12-31 $2,258,187 26,864